Page last updated: 2024-12-11

17,17-dimethylprostaglandin e2

Description

17,17-dimethylprostaglandin E2 (17,17-dimethyl-PGE2) is a synthetic analog of prostaglandin E2 (PGE2), a naturally occurring hormone-like substance involved in various physiological processes.

**Here's why it's important for research:**

* **Enhanced Stability and Activity:** 17,17-dimethyl-PGE2 has a methyl group added at the 17th carbon, which enhances its stability and allows it to persist longer in the body than natural PGE2. This makes it more suitable for research purposes, as it can be studied for longer durations and with less frequent administration.
* **Selective Activity:** 17,17-dimethyl-PGE2 exhibits more selective activity towards specific prostaglandin receptors than PGE2. This specificity allows researchers to better understand the roles of individual receptors in various physiological processes.
* **Improved Pharmacokinetic Properties:** This analog often has better pharmacokinetic properties, including increased absorption, distribution, and half-life. This means it can be more readily studied in various animal models and potentially translated to human studies.

**Research Applications of 17,17-dimethyl-PGE2:**

1. **Prostaglandin Receptor Research:** Studies using 17,17-dimethyl-PGE2 have contributed significantly to understanding the function of different prostaglandin receptors, particularly the EP receptors (EP1, EP2, EP3, and EP4), which are involved in various physiological functions, including inflammation, pain, and vascular regulation.

2. **Inflammation Research:** 17,17-dimethyl-PGE2 has been used to investigate the role of PGE2 in inflammatory processes. Its selectivity for certain EP receptors allows researchers to dissect the specific mechanisms of PGE2-mediated inflammation.

3. **Pain Research:** 17,17-dimethyl-PGE2's ability to interact with EP receptors involved in pain signaling makes it a valuable tool for studying and potentially treating pain conditions.

4. **Wound Healing and Tissue Regeneration:** PGE2 is known to promote wound healing and tissue regeneration, and 17,17-dimethyl-PGE2 has been investigated as a potential therapeutic agent to accelerate these processes.

5. **Cardiovascular Research:** This analog has been used to study the effects of PGE2 on blood pressure regulation, vascular smooth muscle contraction, and other cardiovascular functions.

**Overall:** 17,17-dimethyl-PGE2 serves as a powerful tool for researchers studying the complex and diverse actions of prostaglandins. Its enhanced stability, selective activity, and improved pharmacokinetics make it a valuable model for investigating the physiological roles of these important signaling molecules.

17,17-dimethylprostaglandin E2: prostaglandin E antag [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6439547
MeSH IDM0101461

Synonyms (5)

Synonym
80003-50-5
17,17-dimethyl-pge2
prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-17,17-dimethyl-9-oxo-, (5z,11alpha,13e,15s)-
17,17-dimethylprostaglandin e2
(z)-7-[(1r,2r,3r)-3-hydroxy-2-[(e,3s)-3-hydroxy-5,5-dimethyloct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com